Related Experiment Video
Updated: May 21, 2026

Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment
Published on: August 2, 2024
Impact of Donor Left Ventricular Geometric Remodeling and Hypertrophy on Heart Acceptance and Recipient Survival
Christian O'Donnell1, Juka S Kim2, Akansha Tarun1
1Division of Cardiothoracic Anesthesiology, Stanford University School of Medicine, Stanford, California, USA.
Insights
Classifying donor hearts by geometric remodeling, not just wall thickness, may increase acceptance rates without impacting patient survival. This study analyzed donor heart remodeling patterns and their effect on transplant outcomes.
Area of Science:
- Cardiology
- Transplant Surgery
- Medical Imaging
Background:
- Current donor heart screening relies solely on left ventricular (LV) wall thickness, overlooking diverse geometric remodeling patterns.
- These patterns, crucial in other cardiovascular conditions, haven't been assessed in donor heart evaluation.
Purpose of the Study:
- To determine the prevalence of LV geometric remodeling patterns in brain-dead donor hearts.
- To evaluate the clinical impact of these patterns on donor heart acceptance and recipient survival.
Main Methods:
- Utilized echocardiograms from 3,647 brain-dead donors (February 2015-May 2020) in the Donor Heart Study (DHS).
- Classified LV geometric remodeling using American Society of Echocardiography (ASE) guidelines.
- Compared remodeling patterns and LV wall thickness (>1.3 cm) with transplant acceptance and 3-year recipient mortality via multivariable modeling.
Main Results:
- Concentric remodeling was the most frequent pattern (58.5%).
- Increased LV wall thickness often indicated concentric remodeling (52.1%), not solely concentric hypertrophy (43.8%).
- Neither LV wall thickness, concentric remodeling, nor concentric hypertrophy significantly correlated with 3-year recipient survival.
Conclusions:
- Classifying donor hearts by LV geometric remodeling patterns could potentially decrease rejections due to perceived "hypertrophy."
- This refined assessment may expand the donor pool without negatively affecting patient outcomes.
Background:
Current guidelines recommend screening donor hearts for hypertrophy using solely left ventricular (LV) wall thickness measurements, but this does not capture the type of LV geometric remodeling. Remodeling patterns have been shown to be predictive of clinical outcomes in many cardiovascular diseases but have not been evaluated in donor heart assessment.
Objectives:
The purpose of this study was to describe the prevalence and clinical impact of geometric remodeling patterns in brain-dead donor heart acceptance and recipient survival.
Methods:
The DHS (Donor Heart Study) collected echocardiograms from brain-dead donors across the United States from February 2015 to May 2020. Donor hearts were classified by LV geometric remodeling patterns using ASE (American Society of Echocardiography) guidelines and were compared with LV wall thickness measurements of >1.3 cm for the association with transplant acceptance and 3-year recipient mortality, using multivariable modeling.
Results:
Concentric remodeling (58.5%) was the most common geometric remodeling pattern in 3,647 brain dead donors. Donor hearts with increased LV wall thickness (>1.3 cm) were more likely reclassified as concentric remodeling (52.1%) than concentric hypertrophy (43.8%). Donors with nonacceptance surveys (n = 1,874) commonly (20.3%) had LV hypertrophy listed as a reason for rejection, but most of those hearts had normal geometry (10.8%) or concentric remodeling (60.0%). Neither increased LV wall thickness (adjusted HR [aHR]: 0.94; 95% CI: 0.73-1.21), concentric remodeling (aHR: 1.13; 95% CI: 0.86-1.47), nor concentric hypertrophy (aHR: 0.64; 95% CI: 0.35-1.15) correlated with 3-year recipient survival.
Conclusions:
Classifying donor hearts using LV geometric remodeling patterns may reduce the number turned down for "hypertrophy" without compromising recipient survival.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
